Articulate Biosciences

medical devices

About

Articulate Biosciences is a preclinical stage medical device company, developing a portfolio of products addressing indications in orthopedics and soft tissue repair. The ABX Viscoelastic product family is a series of injectable gels that are biocompatible, cushioning, and lubricating, with an initial target focus in treating osteoarthritis. Preclinical tests have demonstrated protection of cartilage and absence of adverse events in small and large animal studies. Articulate Biosciences is currently conducting additional preclinical studies in preparation for a first-in-human clinical trial. || JLABS selected company, 2018 || || Winner, 2017 Massachusetts Medical Device Development Center (M2D2) $100k Challenge || Contact: [email protected]

Technologies

Gmail Google Apps Google Cloud Hosting Varnish Wix Mobile Friendly Google Analytics Google Tag Manager Android IoT Node.js AI Remote

Keywords

medical device development biomaterials polymer chemistry technology transfer strategic partnering medical equipment manufacturing healthcare equipment & supplies preclinical testing biocompatibility testing studies cell biocompatibility biocompatible gels musculoskeletal space tissue restoration consulting services gel sterilization pain relief biocompatible polymers government cartilage protection osteoarthritis treatment regulatory submissions medical equipment and supplies manufacturing b2b injectable joint gels soft tissue repair technology joint pain treatment biocompatibility testing biomaterials innovation medical devices

Location

110 Canal St, Lowell, Massachusetts, United States, 01852

Related Companies

Companies in the same industry